Which resistance gene(s) are present in methicillin‑resistant Staphylococcus aureus (MRSA) isolated from sputum obtained via endotracheal tube in intubated patients with pneumonia or sepsis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

MRSA Resistance Genes in Intubated Pneumonia/Sepsis Patients

MRSA isolated from endotracheal sputum cultures expresses the mecA gene as the primary resistance determinant, which encodes penicillin-binding protein 2a (PBP2a), conferring resistance to all beta-lactam antibiotics. 1

Core Genetic Mechanism

The mecA gene is the fundamental resistance gene that defines methicillin resistance in S. aureus. This gene:

  • Encodes PBP2a, a modified penicillin-binding protein with significantly reduced affinity for beta-lactam antibiotics 2
  • Allows bacterial cell wall synthesis to continue even in the presence of typically inhibitory concentrations of beta-lactams 2
  • Is carried on a mobile genetic element called SCCmec (Staphylococcal Cassette Chromosome mec) 1

Additional Resistance Genes Based on SCCmec Type

The specific SCCmec type determines what additional resistance genes are present:

Hospital-Acquired MRSA (HA-MRSA) - Most Relevant for Your Intubated Patients

HA-MRSA strains typically carry SCCmec types I, II, III, VI, or VIII 2, which may contain:

  • ermA gene: confers erythromycin resistance
  • aadD gene: confers tobramycin resistance
  • tetK gene: confers tetracycline resistance
  • blaZ gene: encodes beta-lactamase for penicillin resistance 3, 4

These types (II, III, VIII) commonly carry multiple additional resistance genes, making HA-MRSA strains resistant to many non-beta-lactam antibiotics with considerable geographic variability 1.

Community-Acquired MRSA (CA-MRSA) - Less Common in Ventilated Patients

CA-MRSA strains carry SCCmec types IV, V, or VII, which generally do NOT carry additional resistance genes beyond mecA 2. However, they may express:

  • luk-PVL gene: encodes Panton-Valentine leukocidin toxin, a virulence factor that destroys white blood cells and causes severe necrotizing pneumonia 2, 5

Clinical Implications for Your Patient Population

For intubated patients with hospital-acquired or ventilator-associated pneumonia, expect HA-MRSA phenotype with:

  1. Universal resistance to all commercially available beta-lactams due to mecA 1
  2. Frequent multidrug resistance to aminoglycosides, macrolides, and tetracyclines due to additional resistance genes on SCCmec types II, III, VIII 2
  3. Preserved susceptibility to vancomycin, linezolid, daptomycin in most cases 1

Molecular Detection

The femA gene (S. aureus species-specific marker) combined with mecA detection allows rapid molecular identification of MRSA directly from endotracheal aspirates within hours, compared to 48-72 hours for culture 6, 7. This multiplex PCR approach has 100% sensitivity and 89.6% specificity for MRSA detection in respiratory specimens 7.

Important caveat: While mecA is the predominant resistance gene, rare variants (mecC) exist but are uncommon in typical ICU settings. The presence of mecA makes the isolate resistant to ALL beta-lactams regardless of in vitro susceptibility testing showing sensitivity to some cephalosporins 1.

References

Related Questions

Should I repeat MRSA (methicillin‑resistant Staphylococcus aureus) screening for a patient who tested negative three weeks ago but now presents with a new septic episode?
In a 77‑year‑old woman with prior Staphylococcus epidermidis bacteremia treated two months ago who now has four months of intermittent sweating and chills, what diagnostic tests should be performed to assess for persistent infection or other causes?
What is the appropriate adult dosing and drug choice for a patient with a positive blood culture for methicillin‑resistant Staphylococcus aureus (MRSA)?
What antibiotic regimen is recommended for a patient with methicillin‑resistant Staphylococcus aureus (MRSA) infection?
What is the optimal management for a 68‑year‑old female in the Intensive Care Unit with generalized fatigue, dyspnea, hypoxia, poor oral intake, suspected sepsis (elevated C‑reactive protein and procalcitonin), a colostomy performed three months ago, and known nasal colonization with methicillin‑resistant Staphylococcus aureus?
What are the recommended systemic treatment options, dosing, and monitoring for a confirmed MRSA infection?
For a patient presenting for medical clearance with an electrocardiogram (ECG) showing intraventricular conduction delay and no prior cardiac history, is a cardiac referral indicated before undergoing surgery requiring general anesthesia?
What is the current management of traumatic intracranial hemorrhage?
What is the plasmid‑borne ampC (ampC β‑lactamase) gene?
In a 7‑year‑old child with Raynaud syndrome after seven days of heparin who now has progressive thrombocytosis (platelet count rising from 540 ×10⁹/L to 645 ×10⁹/L to 909 ×10⁹/L), what is the likely cause and is anticoagulation with warfarin or antiplatelet therapy with aspirin indicated?
What is the appropriate treatment for pericarditis in a patient with systemic lupus erythematosus?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.